126 related articles for article (PubMed ID: 33847981)
21. Standardized Markerless Gene Integration for Pathway Engineering in Yarrowia lipolytica.
Schwartz C; Shabbir-Hussain M; Frogue K; Blenner M; Wheeldon I
ACS Synth Biol; 2017 Mar; 6(3):402-409. PubMed ID: 27989123
[TBL] [Abstract][Full Text] [Related]
22. Guide RNA Engineering Enables Dual Purpose CRISPR-Cpf1 for Simultaneous Gene Editing and Gene Regulation in
Ramesh A; Ong T; Garcia JA; Adams J; Wheeldon I
ACS Synth Biol; 2020 Apr; 9(4):967-971. PubMed ID: 32208677
[No Abstract] [Full Text] [Related]
23. Gene Excision by Dual-Guide CRISPR-Cas9.
Spagnuolo M; Blenner M
Methods Mol Biol; 2021; 2307():85-94. PubMed ID: 33847983
[TBL] [Abstract][Full Text] [Related]
24. CRISPRi repression of nonhomologous end-joining for enhanced genome engineering via homologous recombination in Yarrowia lipolytica.
Schwartz C; Frogue K; Ramesh A; Misa J; Wheeldon I
Biotechnol Bioeng; 2017 Dec; 114(12):2896-2906. PubMed ID: 28832943
[TBL] [Abstract][Full Text] [Related]
25. Advancing metabolic engineering of Yarrowia lipolytica using the CRISPR/Cas system.
Shi TQ; Huang H; Kerkhoven EJ; Ji XJ
Appl Microbiol Biotechnol; 2018 Nov; 102(22):9541-9548. PubMed ID: 30238143
[TBL] [Abstract][Full Text] [Related]
26. Implementing CRISPR-Cas technologies in conventional and non-conventional yeasts: Current state and future prospects.
Raschmanová H; Weninger A; Glieder A; Kovar K; Vogl T
Biotechnol Adv; 2018; 36(3):641-665. PubMed ID: 29331410
[TBL] [Abstract][Full Text] [Related]
27. Advances and opportunities in gene editing and gene regulation technology for Yarrowia lipolytica.
Ganesan V; Spagnuolo M; Agrawal A; Smith S; Gao D; Blenner M
Microb Cell Fact; 2019 Nov; 18(1):208. PubMed ID: 31783869
[TBL] [Abstract][Full Text] [Related]
28. Validating genome-wide CRISPR-Cas9 function improves screening in the oleaginous yeast Yarrowia lipolytica.
Schwartz C; Cheng JF; Evans R; Schwartz CA; Wagner JM; Anglin S; Beitz A; Pan W; Lonardi S; Blenner M; Alper HS; Yoshikuni Y; Wheeldon I
Metab Eng; 2019 Sep; 55():102-110. PubMed ID: 31216436
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide functional screens enable the prediction of high activity CRISPR-Cas9 and -Cas12a guides in Yarrowia lipolytica.
Baisya D; Ramesh A; Schwartz C; Lonardi S; Wheeldon I
Nat Commun; 2022 Feb; 13(1):922. PubMed ID: 35177617
[TBL] [Abstract][Full Text] [Related]
30. Golden Gate-based metabolic engineering strategy for wild-type strains of Yarrowia lipolytica.
Egermeier M; Sauer M; Marx H
FEMS Microbiol Lett; 2019 Feb; 366(4):. PubMed ID: 30698703
[TBL] [Abstract][Full Text] [Related]
31. High-Efficiency Multiplexed Cytosine Base Editors for Natural Product Synthesis in
Ganesan V; Monteiro L; Pedada D; Stohr A; Blenner M
ACS Synth Biol; 2023 Oct; 12(10):3082-3091. PubMed ID: 37768786
[No Abstract] [Full Text] [Related]
32. Advancing Yarrowia lipolytica as a superior biomanufacturing platform by tuning gene expression using promoter engineering.
Sun ML; Shi TQ; Lin L; Ledesma-Amaro R; Ji XJ
Bioresour Technol; 2022 Mar; 347():126717. PubMed ID: 35031438
[TBL] [Abstract][Full Text] [Related]
33. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
[TBL] [Abstract][Full Text] [Related]
34. Characterization of an efficient CRISPR-iCas9 system in Yarrowia lipolytica for the biosynthesis of carotenoids.
Chen QH; Qian YD; Niu YJ; Hu CY; Meng YH
Appl Microbiol Biotechnol; 2023 Oct; 107(20):6299-6313. PubMed ID: 37642716
[TBL] [Abstract][Full Text] [Related]
35. Expansion of YALIcloneHR toolkit for Yarrowia lipolytica combined with Golden Gate and CRISPR technology.
Shen Q; Yan F; Li YW; Wang J; Ji J; Yan WX; He DC; Song P; Shi TQ
Biotechnol Lett; 2024 Feb; 46(1):37-46. PubMed ID: 38064043
[TBL] [Abstract][Full Text] [Related]
36. A review of synthetic biology tools in Yarrowia lipolytica.
Cao L; Li J; Yang Z; Hu X; Wang P
World J Microbiol Biotechnol; 2023 Mar; 39(5):129. PubMed ID: 36944859
[TBL] [Abstract][Full Text] [Related]
37. A new approach to Cas9-based genome editing in Aspergillus niger that is precise, efficient and selectable.
Leynaud-Kieffer LMC; Curran SC; Kim I; Magnuson JK; Gladden JM; Baker SE; Simmons BA
PLoS One; 2019; 14(1):e0210243. PubMed ID: 30653574
[TBL] [Abstract][Full Text] [Related]
38. Genome Editing in Y. lipolytica Using TALENs.
Rigouin C; Croux C; Dubois G; Daboussi F; Bordes F
Methods Mol Biol; 2021; 2307():25-39. PubMed ID: 33847980
[TBL] [Abstract][Full Text] [Related]
39. A Novel Cre/
Zhou Q; Jiao L; Li W; Hu Z; Li Y; Zhang H; Yang M; Xu L; Yan Y
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639080
[TBL] [Abstract][Full Text] [Related]
40. CRISPR/Cas9-mediated genome editing in sea urchins.
Lin CY; Oulhen N; Wessel G; Su YH
Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
